Analystreport

TG Therapeutics (NASDAQ:TGTX) had its price target raised by analysts at B. Riley from $53.00 to $55.00. They now have a "buy" rating on the stock.

TG Therapeutics, Inc.  (TGTX) 
Last tg therapeutics, inc. earnings: 11/12 07:34 am Check Earnings Report
US:NASDAQ Investor Relations: ir.tgtherapeutics.com